{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:00:17Z","timestamp":1767848417350,"version":"3.49.0"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MCT78568"],"award-info":[{"award-number":["MCT78568"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heart and Stroke Foundation of Canada (CA)","award":["T6157, T6950, NA6186"],"award-info":[{"award-number":["T6157, T6950, NA6186"]}]},{"name":"Australian and New Zealand College of Anesthetists Research Foundation","award":["07\/23"],"award-info":[{"award-number":["07\/23"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198285","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T17:45:45Z","timestamp":1527875145000},"page":"e0198285","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6053-689X","authenticated-orcid":true,"given":"Menaka","family":"Pai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neill K. J.","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Heels-Ansdell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoanna","family":"Skrobik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Qushmaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Meade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan O.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Burry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilton","family":"Brand\u00e3o da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubens","family":"Costa Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Alves Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the PROTECT (Prophylaxis for Thromboembolism in Critical Care Trial) Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1378\/chest.15-0287","article-title":"VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock","volume":"148","author":"D Kaplan","year":"2015","journal-title":"Chest"},{"issue":"14","key":"ref2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","article-title":"Dalteparin versus unfractionated heparin in critically ill patients","volume":"364","author":"D Cook","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"2 Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"SR Kahn","year":"2012","journal-title":"Chest"},{"issue":"2 Suppl","key":"ref4","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"LA Linkins","year":"2012","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0950-3536(05)80017-4","article-title":"Pharmacokinetics of heparin and low molecular weight heparin","volume":"3","author":"B Boneu","year":"1990","journal-title":"Bailliere's Clin Haematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0030-1248722","article-title":"Disorders of hemostasis associated with chronic kidney disease","volume":"36","author":"DI Jalal","year":"2010","journal-title":"Seminars in thrombosis and hemostasis"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"C Kearon","year":"2016","journal-title":"Chest"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-144-9-200605020-00011","article-title":"Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal dysfunction","volume":"144","author":"W Lim","year":"2006","journal-title":"Annals of internal medicine"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1160\/TH10-09-0614","article-title":"CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal dysfunction","volume":"105","author":"R Bauersachs","year":"2011","journal-title":"Thrombosis and haemostasis"},{"issue":"16","key":"ref10","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/archinte.168.16.1805","article-title":"Prophylaxis against deep vein thrombosis in critically ill patients with severe renal dysfunction with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study","volume":"168","author":"J Douketis","year":"2008","journal-title":"Archives of internal medicine"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jcrc.2005.09.009","article-title":"Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal dysfunction","volume":"20","author":"CG Rabbat","year":"2005","journal-title":"Journal of critical care"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1538-7836.2009.03292.x","article-title":"Study of bioaccumulation of dalteparin at a prophylactic dose in patients with various degrees of impaired renal function","volume":"7","author":"P Schmid","year":"2009","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1538-7836.2010.03749.x","article-title":"Prospective observational cohort study of bioaccumulation of dalteparin at a prophylactic dose in patients with peritoneal dialysis","volume":"8","author":"P Schmid","year":"2010","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"DW Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"ref15","first-page":"A1582","article-title":"Adjudication Calibration for Pulmonary Embolism in a Thromboprophylaxis Trial [abstract]","volume":"179","author":"N Zytaruk","year":"2009","journal-title":"Am J Resp Crit Care Med"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.thromres.2012.12.005","article-title":"Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness","volume":"131","author":"DM Arnold","year":"2013","journal-title":"Thrombosis research"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0272-6386(12)80429-X","article-title":"Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia. American journal of kidney diseases: the official journal of the","volume":"22","author":"A Benigni","year":"1993","journal-title":"National Kidney Foundation"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1681\/ASN.V5136","article-title":"Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease","volume":"5","author":"MP Gawaz","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.97.3.251","article-title":"Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor","volume":"97","author":"Z Xiao","year":"1998","journal-title":"Circulation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T22:48:59Z","timestamp":1661381339000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198285"}},"subtitle":[],"editor":[{"given":"Hugo","family":"ten Cate","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198285","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}